Background: Dyspnea is a common, distressing symptom of cardiopulmonary and neuromuscular diseases. Since the ATS published a consensus statement on dyspnea in 1999, there has been enormous growth in knowledge about the neurophysiology of dyspnea and increasing interest in dyspnea as a patient-reported outcome.
Purpose: The purpose of this document is to update the 1999 ATS Consensus Statement on dyspnea.
Background: Persons with chronic illness commonly report fatigue. Measurement of perceived self-efficacy for fatigue self-management (PSEFSM) is essential if fatigue is to be monitored and enhanced to improve physical functional status.
Objective: The objective of the study was to describe the development and testing of the PSEFSM instrument.
Background: Critical gaps exist in the understanding of cancer symptoms, particularly for cancer-related fatigue (CRF). Existing theories and models do not examine the key role perceived self-efficacy (PSE) plays in a person's ability to manage symptoms.
Objectives: The objective of this study was to test the hypothesis that physical functional status (PFS) is predicted through patient characteristics, CRF, other symptoms, and PSE for fatigue self-management in persons with cancer.
Purpose/objectives: To examine the relationships among pain, fatigue, insomnia, and gender while controlling for age, comorbidities, and stage of cancer in patients newly diagnosed with lung cancer within 56 days of receiving chemotherapy.
Design: Secondary data analysis.
Setting: Accrual from four sites: two clinical community oncology programs and two comprehensive cancer centers.
Objectives: To examine the current research related to symptom clusters in specific cancer diagnoses.
Data Sources: Research studies, review articles.
Conclusion: Factors that can impact symptoms and their relationship include the stage of disease, treatment used, modification of treatment for the individual patient, patient co-morbidities as well as psychological, sociological, and cultural factors.
Purpose/objectives: To identify the number, type, and combination (cluster) of symptoms experienced by patients with lung cancer.
Design: A secondary analysis of data collected as part of a larger study.
Setting: 24 sites that included community hospitals, medical clinics, oncology clinics, and radiation-oncology clinics.
Background: Patients with lung cancer present late in the disease and have multiple symptoms. Previous research has shown the symptom cluster of fatigue, weakness, weight loss, appetite loss, nausea, vomiting, and altered taste to be present at time of lung cancer diagnosis.
Objectives: The study determined whether the symptom cluster identified at the time of diagnosis remained 3 and 6 months later, and whether there was a difference in the mean number of symptoms and the mean level of symptom severity over time.